GGrantIndex
← Leaderboards

Verena Staedtke

Johns Hopkins University

$2,886,690
Attributed
$4,422,420
Total exposure
2
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $916.4K · FY201824
$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$4,422,420 · 2

By mechanism

U01$3,071,460 · 1
K08$1,350,960 · 1

Top collaborators

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Neoplastic Cell

Research focus

Neoplastic CellMouse ModelImmunotherapyMyeloid CellsMalignant NeoplasmsMediatingHematologic NeoplasmsImmune-Related Adverse EventsInterleukin-6Knock-OutCytokine Release SyndromeAntitumor ResponseEpinephrineEffective InterventionCatecholaminesCd19 GeneImmuneCancer TherapyCellsImmunotoxicityB Lymphoid MalignancyChimeric Antigen ReceptorCytokineProduction

Grant awards (11)

Adrenergic modulation of cellular immune functions in CAR T cell-induced cytokine release syndrome$582,680
U01 · FY2024 · CA · contact PI
Adrenergic modulation of cellular immune functions in CAR T cell-induced cytokine release syndrome$1
U01 · FY2024 · CA · contact PI
Adrenergic modulation of cellular immune functions in CAR T cell-induced cytokine release syndrome$613,864
U01 · FY2023 · CA · contact PI
Adrenergic modulation of cellular immune functions in CAR T cell-induced cytokine release syndrome$614,372
U01 · FY2022 · CA · contact PI
The role of catecholamines in immunotoxicity and tumor response of adoptive T cell therapy in cancer$270,192
K08 · FY2022 · CA · contact PI
Adrenergic modulation of cellular immune functions in CAR T cell-induced cytokine release syndrome$614,362
U01 · FY2021 · CA · contact PI
The role of catecholamines in immunotoxicity and tumor response of adoptive T cell therapy in cancer$270,192
K08 · FY2021 · CA · contact PI
Adrenergic modulation of cellular immune functions in CAR T cell-induced cytokine release syndrome$646,181
U01 · FY2020 · CA · contact PI
The role of catecholamines in immunotoxicity and tumor response of adoptive T cell therapy in cancer$270,192
K08 · FY2020 · CA · contact PI
The role of catecholamines in immunotoxicity and tumor response of adoptive T cell therapy in cancer$270,192
K08 · FY2019 · CA · contact PI
The role of catecholamines in immunotoxicity and tumor response of adoptive T cell therapy in cancer$270,192
K08 · FY2018 · CA · contact PI